Zobrazeno 1 - 5
of 5
pro vyhledávání: '"59"'
Autor:
Luca Federici, Sebastiano Miscia, Nicola Tinari, Damiana Pieragostino, Pietro Di Marino, Luciana Irtelli, Rosalba Florio, Marco Marchisio, Antonino Grassadonia, Pasquale Simeone, Laura De Lellis, Paola Lanuti, Michele De Tursi, Maria Concetta Cufaro, Piero Del Boccio, Alessandro Cama, Serena Veschi, Giuseppina Bologna, Davide Brocco
Publikováno v:
Cancers, Vol 13, Iss 585, p 585 (2021)
Cancers
Volume 13
Issue 4
Cancers
Volume 13
Issue 4
Simple Summary Purpose of this study was to investigate the prognostic and predictive role of blood circulating extracellular vesicles (EVs) in patients with advanced non-small cell lung cancer treated with immunotherapy. A newly optimized flow cytom
Autor:
Alfonso De Stefano, Antonella Petrillo, Luca Brunese, Vincenza Granata, Roberta Fusco, Alessandro Ottaiano, Antonio Avallone, Francesco Izzo, Carolina Sbordone
Publikováno v:
Cancers, Vol 13, Iss 453, p 453 (2021)
Cancers
Volume 13
Issue 3
Cancers
Volume 13
Issue 3
Purpose: To assess the association of RAS mutation status and radiomics-derived data by Contrast Enhanced-Magnetic Resonance Imaging (CE-MRI) in liver metastases. Materials and Methods: 76 patients (36 women and 40 men
59 years of mean age and 3
59 years of mean age and 3
Autor:
János Kappelmayer, Katalin Gyurina, Ágnes Vojczek, Lilla Gyorgyi Tiszlavicz, Gábor T. Kovács, Karin Nebral, Angela Schumich, Csongor Kiss, A Kolenova, Łukasz Sędek, Pál Jáksó, Andishe Attarbaschi, Oskar A. Haas, Attila Nagy, Zsuzsanna Hevessy, Peter Svec, Gábor Barna, Eszter Szánthó, Bettina Kárai, Michael Dworzak, István Szegedi, Tomasz Szczepański, Anikó Ujfalusi, Jerzy Kowalczyk, Judit Müller, Réka Simon
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2264, p 2264 (2020)
Volume 12
Issue 8
Cancers, Vol 12, Iss 2264, p 2264 (2020)
Volume 12
Issue 8
Background: Based on previous retrospective results, we investigated the association of coagulation FXIII subunit A (FXIII-A) expression pattern on survival and correlations with known prognostic factors of B-cell progenitor (BCP) childhood acute lym
Autor:
S. Servagi-Vernat, Christine Hoeffel, Jean-Claude Merol, Esteban Brenet, Coralie Barbe, Marc Labrousse, Léa Fath, Xavier Dubernard
Publikováno v:
Cancers
Cancers, MDPI, 2020, 12 (5), pp.1234. ⟨10.3390/cancers12051234⟩
Cancers, Vol 12, Iss 1234, p 1234 (2020)
Volume 12
Issue 5
Cancers, MDPI, 2020, 12 (5), pp.1234. ⟨10.3390/cancers12051234⟩
Cancers, Vol 12, Iss 1234, p 1234 (2020)
Volume 12
Issue 5
Aims: To investigate the predictive capacity of early post-treatment diffusion-weighted magnetic resonance imaging (MRI) for recurrence or tumor progression in patients with no tumor residue after chemo-radiotherapy (CRT) for head and neck squamous c
Autor:
Matteo Bauckneht 1, Sara Elena Rebuzzi 2, Alessio Signori 3, Maria Isabella Donegani 3, Veronica Murianni 2, Alberto Miceli 3, Roberto Borea 2, Stefano Raffa 3, Alessandra Damassi 2, Marta Ponzano 3, Fabio Catalano 2, Valentino Martelli 2, Cecilia Marini 1, 4, Francesco Boccardo 5, 6, Silvia Morbelli 1, 3, Gianmario Sambuceti 1, Giuseppe Fornarini 2
Publikováno v:
Cancers (Basel) 12 (2020): E3213. doi:10.3390/cancers12113213
info:cnr-pdr/source/autori:Matteo Bauckneht 1, Sara Elena Rebuzzi 2, Alessio Signori 3, Maria Isabella Donegani 3, Veronica Murianni 2, Alberto Miceli 3, Roberto Borea 2, Stefano Raffa 3, Alessandra Damassi 2, Marta Ponzano 3, Fabio Catalano 2, Valentino Martelli 2, Cecilia Marini 1,4, Francesco Boccardo 5,6, Silvia Morbelli 1,3, Gianmario Sambuceti 1,3, Giuseppe Fornarini 2/titolo:The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study/doi:10.3390%2Fcancers12113213/rivista:Cancers (Basel)/anno:2020/pagina_da:E3213/pagina_a:/intervallo_pagine:E3213/volume:12
Cancers
Volume 12
Issue 11
Cancers, Vol 12, Iss 3213, p 3213 (2020)
info:cnr-pdr/source/autori:Matteo Bauckneht 1, Sara Elena Rebuzzi 2, Alessio Signori 3, Maria Isabella Donegani 3, Veronica Murianni 2, Alberto Miceli 3, Roberto Borea 2, Stefano Raffa 3, Alessandra Damassi 2, Marta Ponzano 3, Fabio Catalano 2, Valentino Martelli 2, Cecilia Marini 1,4, Francesco Boccardo 5,6, Silvia Morbelli 1,3, Gianmario Sambuceti 1,3, Giuseppe Fornarini 2/titolo:The Prognostic Role of Baseline Metabolic Tumor Burden and Systemic Inflammation Biomarkers in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223: A Proof of Concept Study/doi:10.3390%2Fcancers12113213/rivista:Cancers (Basel)/anno:2020/pagina_da:E3213/pagina_a:/intervallo_pagine:E3213/volume:12
Cancers
Volume 12
Issue 11
Cancers, Vol 12, Iss 3213, p 3213 (2020)
Simple Summary Radium-223 is an alpha-emitting radioisotope that selectively binds to increased bone turnover areas, such as metastatic sites, acting as a bone-seeking calcium mimetic drug. Its therapeutic function in metastatic castration-resistant